Swiss Re, CH0126881561

Swiss Re stock: Barclays reiterates Sell rating, changes target

Published on 11/20/2026 at 11:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Swiss Re stock faces renewed analyst scrutiny after Barclays retained its Sell rating and changed its price target. The move adds a fresh valuation signal.

Analyst view and target change

  • Barclays retained its Sell rating on Swiss Re.
  • The broker changed its price target from CHF 137 to CHF 122.
  • Swiss Re operates as a global reinsurance group across non-life, life and health reinsurance.
Swiss Re, CH0126881561, Illustration mit AI erstellt.

On November 17, Barclays reiterated its Sell rating on Swiss Re, according to MarketScreener. The report said the broker changed its price target from CHF 137 to CHF 122.

Barclays' rating stance keeps the focus on valuation rather than on a new company filing. For investors, the unchanged Sell recommendation signals that the broker's assessment of Swiss Re's near-term risk and return profile remains cautious, while the target change provides a fresh benchmark for the shares.

What the analyst action means

The target change comes after Swiss Re reported nine-month 2026 net income of USD 4.2 billion on November 5 and maintained its USD 4.5 billion full-year net income target. The company attributed the result to contributions across its business units, lower-than-expected natural catastrophe losses and a solid investment result.

The operating backdrop remains mixed. Swiss Re's property and casualty reinsurance business faces more competitive pricing, while life and health reinsurance has provided support for group earnings. That combination leaves investors weighing strong profitability against the possibility that softer market pricing will constrain future growth.

Swiss Re stock traded at 161.05 euros on Lang & Schwarz at 11:12 CET on Friday, November 20, 2026.

Swiss Re AG

  • Company: Swiss Re AG
  • ISIN: CH0126881561
  • Ticker: SREN.SW
  • Sector: Reinsurance
  • Lang & Schwarz quote: EUR 161.05 at 11:12 CET on November 20, 2026

Swiss Re is scheduled to present detailed financial targets and segment outlooks at its investor presentation on December 4, 2026. That event may give investors more detail on how management intends to balance disciplined underwriting, capital strength and growth in a more competitive pricing environment.

The broader Swiss market is represented by the Swiss Market Index.

More news and analyses on Swiss Re stock

Disclaimer...
en | CH0126881561 | SWISS RE | boerse | 70539609 | bgmi